Revenue (TTM) Chart

View Revenue (TTM) for GDRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (TTM) Chart
Start Trial

Historical Revenue (TTM) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 785.23M
March 31, 2026 787.89M
December 31, 2025 796.85M
September 30, 2025 800.65M
June 30, 2025 799.87M
March 31, 2025 797.41M
December 31, 2024 792.32M
September 30, 2024 790.38M
June 30, 2024 775.09M
March 31, 2024 764.16M
December 31, 2023 750.26M
September 30, 2023 737.73M
June 30, 2023 745.09M
March 31, 2023 747.21M
Date Value
December 31, 2022 766.55M
September 30, 2022 795.70M
June 30, 2022 803.48M
March 31, 2022 788.32M
December 31, 2021 745.42M
September 30, 2021 685.71M
June 30, 2021 631.06M
March 31, 2021 577.72M
December 31, 2020 550.70M
September 30, 2020 510.41M
June 30, 2020 471.70M
March 31, 2020 439.94M
December 31, 2019 388.22M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

View Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (TTM) Benchmarks

View Revenue (TTM) Benchmarks
Start Trial
LataMed AI Corp. 0.00
SCWorx Corp. 2.926M
Health Catalyst, Inc. 292.24M
Claritev Corp. 994.67M
iSpecimen, Inc. 0.4663M